UBUD:F:F-UBS (Irl) ETF Public Limited Company - Solactive Global Pure Gold Miners UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 27.37

Change

0.00 (0.00)%

Market Cap

USD 0.27B

Volume

7.84K
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.14 (-0.27%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-3.92 (-0.70%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.70 (-0.30%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-0.74 (-0.74%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 46.87B
0ZC:F Zscaler Inc

+0.35 (+0.16%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.68%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.74 (-0.58%)

USD 24.77B

ETFs Containing UBUD:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 45.48% 98% N/A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.48% 98% N/A 92% A
Trailing 12 Months  
Capital Gain 66.77% 98% N/A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.77% 96% N/A 87% B+
Trailing 5 Years  
Capital Gain 75.58% 71% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 75.58% 71% C- 53% F
Average Annual (5 Year Horizon)  
Capital Gain 8.28% 64% D 62% D
Dividend Return 8.28% 61% D- 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.56% 14% F 55% F
Risk Adjusted Return 32.38% 43% F 54% F
Market Capitalization 0.27B 47% F 41% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.